A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...
Prostate cancer is among the most prevalent cancers in men, particularly above the age of 50. In India, prostate cancer has been increasingly reported, with the urban population being at a higher risk ...
Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...
If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results